TY - JOUR

T1 - Оценка и сравнение рефракционных результатов имплантации отечественной ИОЛ MIOL-SOFT-2-13 с зарубежными моделями

AU - Николаенко, Вадим Петрович

AU - Белов, Дмитрий Федорович

AU - Ковалева, Виктория Викторовна

PY - 2024/6/26

Y1 - 2024/6/26

N2 - purpose. Evaluation and refractive results comparison of MIOLSOFT213 (ReperNN, Russia) IOL implantation with foreign models. material and methods. The study included 816 patients (816 eyes) who underwent phacoemulsification (PE) with IOL implantation, divided into four groups depending on IOL model: MIOLSOFT213 (ReperNN, Russia) (n = 199); SA60AT (Alcon, USA) (n = 237); Adapt AO (Bausch&Lomb, USA) (n = 179); Acryfold 601 (Appasamy Associates, India) (n = 201). All patients underwent optical biometry using IOLMaster 500 (Carl Zeiss, Germany). A month after PE spherical equivalent of refraction was assessed by Topcon8800 (Japan). Mean calculation error (ME) and mean absolute error (MAE) were used as a IOL calculation accuracy criterion. results. Zeroing of ME allowed to determine real aconstant of MIOLSOFT213 (119.83 instead of 118.4 declared by the manufacturer). MAE in the groups was: 0.39 ± 0.27, 0.33 ± 0.35, 0.38 ± 0.31 and 0.38 ± 0.30 D, respectively (p = 0.068). All IOLs demonstrated hitting the target refraction within ±1.00 D in more than 95 % of cases. Conclusion. MIOLSOFT213 has comparable refractive results with other monofocal IOLs used in national medical insurance system. MIOLSOFT213 achieves target refraction within ±1.00 D in 98 % of cases. To obtain optimal refractive results, an optimized aconstant of 118.83 is required.

AB - purpose. Evaluation and refractive results comparison of MIOLSOFT213 (ReperNN, Russia) IOL implantation with foreign models. material and methods. The study included 816 patients (816 eyes) who underwent phacoemulsification (PE) with IOL implantation, divided into four groups depending on IOL model: MIOLSOFT213 (ReperNN, Russia) (n = 199); SA60AT (Alcon, USA) (n = 237); Adapt AO (Bausch&Lomb, USA) (n = 179); Acryfold 601 (Appasamy Associates, India) (n = 201). All patients underwent optical biometry using IOLMaster 500 (Carl Zeiss, Germany). A month after PE spherical equivalent of refraction was assessed by Topcon8800 (Japan). Mean calculation error (ME) and mean absolute error (MAE) were used as a IOL calculation accuracy criterion. results. Zeroing of ME allowed to determine real aconstant of MIOLSOFT213 (119.83 instead of 118.4 declared by the manufacturer). MAE in the groups was: 0.39 ± 0.27, 0.33 ± 0.35, 0.38 ± 0.31 and 0.38 ± 0.30 D, respectively (p = 0.068). All IOLs demonstrated hitting the target refraction within ±1.00 D in more than 95 % of cases. Conclusion. MIOLSOFT213 has comparable refractive results with other monofocal IOLs used in national medical insurance system. MIOLSOFT213 achieves target refraction within ±1.00 D in 98 % of cases. To obtain optimal refractive results, an optimized aconstant of 118.83 is required.

KW - IOL calculation

KW - IOL calculation formula

KW - ReperNN

KW - aconstant

KW - biometry

KW - intraocular lens

KW - phacoemulsification

UR - https://www.mendeley.com/catalogue/c244a795-7c56-377c-a4d7-411ab8f04f26/

U2 - 10.18008/1816-5095-2024-2-289-295

DO - 10.18008/1816-5095-2024-2-289-295

M3 - статья

VL - 21

SP - 289

EP - 295

JO - Офтальмология

JF - Офтальмология

SN - 1816-5095

IS - 2

ER -